Cibus (CBUS) Intangibles (2022 - 2026)
Cibus (CBUS) posted Intangibles of $31.7 million for Q4 2025, down 1.42% sequentially from $32.1 million in Q3 2025, and down 5.66% YoY from $33.6 million in Q4 2024.
Cibus (CBUS) Intangibles (2022 - 2026) Analysis & Trends
Cibus has reported Intangibles for 4 years, with the latest figure at $31.7 million in Q4 2025.
- Quarterly Intangibles fell 5.66% year-over-year to $31.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.7 million (down 5.66% YoY) and the FY2025 annual result came in at $31.7 million, down 5.66% from the prior year.
- Intangibles retreated to $31.7 million in Q4 2025 per CBUS's latest filing, from $32.1 million in the prior quarter.
- Over five years, Intangibles peaked at $135.4 million in Q2 2023 and troughed at $158000.0 in Q4 2022.
- A 4-year average of $47.7 million and a median of $33.8 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2024: Intangibles surged 22312.03% in 2023, then sank 74.77% in 2024.
- Over 4 years, Intangibles stood at $158000.0 in 2022, then soared by 22312.03% to $35.4 million in 2023, then fell by 5.18% to $33.6 million in 2024, then fell by 5.66% to $31.7 million in 2025.
- According to Business Quant data, Intangibles over the past three periods registered $31.7 million, $32.1 million, and $32.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 93.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 30.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.77 Mn |
| Dec 31, 2025 | 31.68 Mn |
| Sep 30, 2025 | 32.13 Mn |
| Jun 30, 2025 | 32.59 Mn |
| Mar 31, 2025 | 33.04 Mn |
| Dec 31, 2024 | 33.58 Mn |
| Sep 30, 2024 | 34.04 Mn |
| Jun 30, 2024 | 34.49 Mn |
| Mar 31, 2024 | 34.95 Mn |
| Dec 31, 2023 | 35.41 Mn |
| Sep 30, 2023 | 134.92 Mn |
| Jun 30, 2023 | 135.38 Mn |
| Dec 31, 2022 | 158,000.00 |